Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: Protective effect of curcumin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 3, 2012, Pages

  Izem Meziane, Malika ^a   Djerdjouri, Bahia ^a   Rimbaud, Stephanie ^b,c   Caffin, Fanny ^b,c   Fortin, Dominique ^b,c   Garnier, Anne ^b,c   Veksler, Vladimir ^b,c   Joubert, Frederic ^b,c   Ventura Clapier, Renee ^b,c  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cardiac injury; Curcumin; Isoprenaline; Mitochondria function; Mitochondrial morphology and permeability transition pore

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CURCUMIN; ISOPRENALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOGENESIS; CARDIOTOXICITY; CELL DAMAGE; CELL RESPIRATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART PROTECTION; ISCHEMIA; MALE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MITOCHONDRION SWELLING; MORPHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; CARDIOMEGALY; CARDIOTONIC AGENTS; CATECHOLAMINES; CURCUMIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; ISOPROTERENOL; MALE; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDITIS; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84856480096     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00467.2011     Document Type: Article

References (49)

1. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
2. Azzolin L, von Stockum S, Basso E, Petronilli V, Forte MA, Bernardi P. The mitochondrial permeability transition from yeast to mammals. FEBS Lett 584: 2504-2509, 2010.
3. Boyne AF, Ellman GL. A methodology for analysis of tissue sulfhydryl components. Anal Biochem 46: 639-653, 1972.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Burelle Y, Khairallah M, Ascah A, Allen BG, Deschepper CF, Petrof BJ, Des Rosiers C. Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J Mol Cell Cardiol 48: 310-21, 2010.
6. Cereghetti GM, Stangherlin A, Martins de Brito O, Chang CR, Blackstone C, Bernardi P, Scorrano L. Dephosphorylation by calcineu-rin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 105: 15803-15808, 2008.
7. Chan DC. Mitochondrial dynamics in disease. N Engl J Med 356: 1707-1709, 2007.
8. Choudhary G, Dudley SC Jr. Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail 8: 148-155, 2002.
9. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8: 939-944, 2007.
10. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations Implications in heart failure. Circ Res 85: 68-76, 1999.
11. Dhalla NS, Dent MR, Arneja AS. Pathogenesis of catecholamine-induced cardiomyopathy. Cardiovasc Toxicol 200: 207-262, 2008.
12. Di Lisa F, Kaludercic N, Carpi A, Menabo R, Giorgio M. Mitochondria and vascular pathology. Pharmacol Rep 61: 123-130, 2009.
13. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276: 2571-2575, 2001.
14. Fiorillo C, Becatti M, Pensalfini A, Cecchi C, Lanzilao L, Donzelli G, Nassi N, Giannini L, Borchi E, Nassi P. Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kap-paB, and JNK pathways. Free Radic Biol Med 45: 839-846, 2008.
15. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501, 2003.
16. Garnier A, Fortin D, Zoll J, N'Guessan B, Mettauer B, Lampert E, Veksler V, Ventura-Clapier R. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J 19: 43-52, 2005.
17. Goto K, Takemura G, Maruyama R, Nakagawa M, Tsujimoto A, Kanamori H, Li L, Kawamura I, Kawaguchi T, Takeyama T, Fuji-wara H, Minatoguchi S. Unique mode of cell death in freshly isolated adult rat ventricular cardiomyocytes exposed to hydrogen peroxide. Med Mol Morphol 42: 92-101, 2009.
18. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 305: 626-629, 2004.
19. Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA. Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279: 21233-21238, 2004.
20. Heath-Engel HM, Shore GC. Mitochondrial membrane dynamics, cris-tae remodelling and apoptosis. Biochim Biophys Acta 1763: 549-560, 2006.
21. Kaplan P, Babusikova E, Lehotsky J, Dobrota D. Free radical-induced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum. Mol Cell Biochem 248: 41-47, 2003.
22. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350, 1984.
23. Kuznetsov AV, Veksler V, Gellerich FN, Saks V, Margreiter R, Kunz WS. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 3: 965-976, 2008.
24. Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, Puvanakrishnan R. Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol 36: 1967-1980, 2004.
25. Marcil M, Ascah A, Matas J, Belanger S, Deschepper CF, Burelle Y. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol 41: 998-1009, 2006.
26. Martinou JC, Youle RJ. Which came first, the cytochrome c release or the mitochondrial fission? Cell Death Differ 13: 1291-1295, 2006.
27. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Na-gasawa A, Komeda M, Fujita M, Shimatsu A, Kita T, Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118: 868-878, 2008.
28. Morin D, Barthelemy S, Zini R, Labidalle S, Tillement JP. Curcumin induces the mitochondrial permeability transition pore mediated by mem brane protein thiol oxidation. FEBS Lett 495: 131-136, 2001.
29. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. Cyclophilin D-depen-dent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652-658, 2005.
30. Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H, Jaleel N, Chua BH, Hewett TE, Robbins J, Houser SR, Molkentin JD. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 117: 2431-2444, 2007.
31. Nazam Ansari M, Bhandari U, Pillai KK. Protective role of curcumin in myocardial oxidative damage induced by isoproterenol in rats. Hum Exp Toxicol 26: 933-938, 2007.
32. Nirmala C, Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159: 85-93, 1996.
33. Nogueira V, Devin A, Walter L, Rigoulet M, Leverve X, Fontaine E. Effects of decreasing mitochondrial volume on the regulation of the permeability transition pore. J Bioenerg Biomembr 37: 25-33, 2005.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
35. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirko-rian G, Monassier JP, Derumeaux G, Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359: 473-481, 2008.
36. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280: 1763-1766, 1998.
37. Singal PK, Khaper N, Palace V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40: 426-432, 1998.
38. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
39. Tanwar V, Sachdeva J, Golechha M, Kumari S, Arya DS. Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of Hsp27 along with strengthening antioxidant defense system. J Cardiovasc Pharmacol 55: 377-384, 2010.
40. Twig G, Hyde B, Shirihai OS. Mtochondrial fusion, fission and au-tophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta 1777: 1092-1097, 2008.
41. Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 3: 221-229, 2005.
42. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892: 191-196, 1987.
43. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79: 208-217, 2008.
44. Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Br J Pharmacol 127: 65-74, 1999.
45. Wahlefeld Lactate Dehydrogenase AW. UV-method with L-Lactate and NAD. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York, NY: Plenum, 1983, p. 126-132.
46. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, Ping P. Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288: H1290-H1295, 2005.
47. Wang SB, Tian S, Yang F, Yang HG, Yang XY, Du GH. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. Eur J Pharmacol 615: 125-132, 2009.
48. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 10: 245-250, 2000.
49. Wongcharoen W, Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133: 145-151, 2009.